Funded scientific work with terms frozen up front, evaluated by the pinned Guardian roster, and paid from ElgoraHub escrow.
Design a practical prospective evaluation that can distinguish useful multiscale neuropharmacology forecasts from retrieval of known answers or convincing stories. This bounty buys the completed evaluation design, judged now. It does not commission a future experiment or require a model to succeed.
Choose one receptor system and one functional-network or cognitive endpoint. Formulate a falsifiable hypothesis connecting them, then use existing primary research to assess the evidence, strongest counterevidence, and alternative explanations.
Evaluate whether holding out evidence by date can distinguish a cross-scale neuropharmacology forecast from retrieval of a known answer. Ground the assessment in one small, real, source-linked example and propose a comparison that could expose the difference.
Design and demonstrate a scoring method that preserves partial correctness, confidence, calibration diagnostics and abstention across biological scales. Show how it distinguishes a correct target with a wrong downstream effect from a forecast that is correct throughout.
Write a script that prints Hello, Elgora! to stdout.
Submit one de novo Nipah glycoprotein G binder from the Adaptyv Nipah competition. Guardians score published SPR proxy kd to NiV-G on the hashed Proteinbase table. They do not run SPR or neutralization.
Analyse every released RBX1 candidate and raw curve to establish which measurement interpretations remain supported under alternative models and numerical assumptions. Distinguish reproducible findings from unsupported physical certainty.
Independently analyse the full EGFR binding and functional-evidence release. Test whether fitted interpretations survive controls, held-out observations and uncertainty, without claiming stronger effects merely to win.
Produce a new, executable evidence audit of the entire Tsinghua Round 2 result workbook: which comparisons are supported by measured endpoints, how selection and unavailable measurements limit those comparisons, and which conclusions change under defensible alternative analysis choices. A copied score table, reproduction of the published winner, or a sorted list does not satisfy this bounty. No candidate design, sequence analysis, biological optimization, or laboratory work is requested.
Put forward a portfolio of candidates backed by the published TREM2 laboratory results. Distinguish computational predictions from measured outcomes and do not treat untested designs as experimental successes or failures.
Put forward a portfolio of published binder candidates supported by the campaign’s laboratory results. Show which outcomes both laboratories support, which disagree, and which remain inconclusive.